Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections
Ger Rijkers, Jean-Luc Murk, Bas Wintermans, Bieke van Looy, Marcel van den Berge, Jacobien Veenemans, Joep Stohr, Chantal Reusken, Pieter van der Pol, Johan Reimerink
doi: https://doi.org/10.1101/2020.06.09.20122036
Ger Rijkers
1Department of Medical Microbiology and Immunology, Admiral De Ruyter Hospital, 4462 RA Goes, The Netherlands
2Microvida, location St. Elisabeth-Tweesteden Hospital, 5022 GC Tilburg, The Netherlands
6Science Department, University College Roosevelt, 4331 CB Middelburg, The Netherlands
Jean-Luc Murk
2Microvida, location St. Elisabeth-Tweesteden Hospital, 5022 GC Tilburg, The Netherlands
Bas Wintermans
1Department of Medical Microbiology and Immunology, Admiral De Ruyter Hospital, 4462 RA Goes, The Netherlands
3Department of Medical Microbiology, Bravis Hospital, 4708 AE Roosendaal, The Netherlands
Bieke van Looy
1Department of Medical Microbiology and Immunology, Admiral De Ruyter Hospital, 4462 RA Goes, The Netherlands
Marcel van den Berge
4Department of Internal Medicine, Admiral De Ruyter Hospital, 4462 RA Goes, The Netherlands
Jacobien Veenemans
1Department of Medical Microbiology and Immunology, Admiral De Ruyter Hospital, 4462 RA Goes, The Netherlands
Joep Stohr
2Microvida, location St. Elisabeth-Tweesteden Hospital, 5022 GC Tilburg, The Netherlands
Chantal Reusken
5WHO COVID-19 Reference Laboratory, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands
PhDPieter van der Pol
1Department of Medical Microbiology and Immunology, Admiral De Ruyter Hospital, 4462 RA Goes, The Netherlands
Johan Reimerink
5WHO COVID-19 Reference Laboratory, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands
Article usage
Posted June 12, 2020.
Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections
Ger Rijkers, Jean-Luc Murk, Bas Wintermans, Bieke van Looy, Marcel van den Berge, Jacobien Veenemans, Joep Stohr, Chantal Reusken, Pieter van der Pol, Johan Reimerink
medRxiv 2020.06.09.20122036; doi: https://doi.org/10.1101/2020.06.09.20122036
Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections
Ger Rijkers, Jean-Luc Murk, Bas Wintermans, Bieke van Looy, Marcel van den Berge, Jacobien Veenemans, Joep Stohr, Chantal Reusken, Pieter van der Pol, Johan Reimerink
medRxiv 2020.06.09.20122036; doi: https://doi.org/10.1101/2020.06.09.20122036
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (628)
- Anesthesia (165)
- Cardiovascular Medicine (2379)
- Dermatology (207)
- Emergency Medicine (379)
- Epidemiology (11775)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3746)
- Geriatric Medicine (350)
- Health Economics (634)
- Health Informatics (2399)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (105)
- Nephrology (398)
- Neurology (3508)
- Nursing (198)
- Nutrition (526)
- Oncology (1825)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (233)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1035)
- Primary Care Research (420)
- Public and Global Health (6145)
- Radiology and Imaging (1280)
- Respiratory Medicine (828)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)